LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIALWolfgang Wick, Martin J. van den Bent, Felix Sahm et al.|Neuro-Oncology|2015Cited by 79
Phase II part of EORTC study 26101: The sequence of bevacizumab and lomustine in patients with first recurrence of a glioblastoma.Wolfgang Wick, Martin J. van den Bent, Roger Stupp et al.|Journal of Clinical Oncology|2016Cited by 19